Patient With Craniopharyngioma

Discussion Craniopharyngioma is a benign growth slow tumor, common in the pituitary gland and the saddle near the optic nerve. The overall incidence of this tumor is about 2% and 6%, the highest incidence among children aged 5 to 14 and adults aged 65 to 74 (1, 2). The incidence does not change depending on sex or race (2). These tumors account for 2-5% of all primary intracranial tumors (3). Clinical symptoms The most common clinical features of craniopharyngioma include headache and visual defect, as well as nausea and vomiting (3, 4).

Craniopharyngioma is a benign tumor derived from the squamous cell nest of the original Lasque bag. It is the most common intracranial tumor in children, accounting for nearly 54% of cases. Central diabetes insipidus and various pituitary hormone deficiencies are common symptoms in children with craniopharyngioma. Surgery is the optimal treatment. A retrospective study of pediatric patients undergoing transarterfoot osseous surgery due to adrenocorticotropic hormone secretory hormone or growth hormone-secreting pituitary adenoma suggests that 26% of patients develop diabetes insipidus, 14% develop vasopressin And showed adequate secretion. Syndrome (SIADH)). Comprehensive risk factors for these postoperative conditions include tumor infiltration into female, posterior pituitary and / or posterior pituitary as well as cerebrospinal fluid leakage or lumbar drainage

The patient had a history of craniopharyngioma at 9 years of age. His tumor was first diagnosed in 2010 and managed in academic hospitals. He was partially excised by the tumor in 2010. The tumor relapsed and he needed to re-examine the tumor in 2013. No radiation therapy was done after both resections. Unfortunately, due to the tumor and initial surgery, he was blind with the left eye, but the right eye was still very good. Craniopharyngioma is a benign tumor that develops to the third ventricle at the bottom of the pituitary brain. They are benign, but they are very positive. Treatment involves surgery and hopes to achieve complete resection. If we can completely eliminate it, no further treatment is needed unless it is regenerated. If we can not get rid of it completely, then the patient will need radiotherapy to destroy the remaining illness.